Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on March 31, 2025

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights
Announced demonstrated ability to deliver transient gene therapy (payload) to tumors using systemic antitumor virotherapy platform Filed IND in March 2025 for CLD-201 company sponsored Phase 1 trial to treat multiple solid tumors Commencement of …

Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome (PWS), with meaningful reductions in hyperphagia (up to a 16-point HQ-CT reduction, with an average reduction of …

Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple milestones anticipated in 2025 including: FDA meeting anticipated in first half 2025 to discuss icovamenib late-stage …

Archimedes Tech SPAC Partners II Co. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing April 3, 2025
CLAYMONT, Del., March 31, 2025 (GLOBE NEWSWIRE) -- Archimedes Tech SPAC Partners II Co. (Nasdaq: ATIIU) (the “Company”) today announced that, commencing April 3, 2025, holders of the units sold in the Company’s initial public offering may elect to …

FRP Holdings Announces Investor Day, Conference Participation and its New Investor Website and Presentation
JACKSONVILLE, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- FRP Holdings, Inc. (NASDAQ: FRPH) announced today several updates regarding its investor engagement initiatives. 2025 Investor Day – Save the Date The Company will host an Investor Day on May 22nd, …

Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, with a …

Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
– Favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year for once daily brilaroxazine in open-label extension (OLE) trial – – Registrational Phase 3 RECOVER-2 trial initiation for brilaroxazine expected mid-2025 – – Full data …

Rekor Systems Reports Strong 2024 Financial Results Highlighted by Record Revenue and Significant Operational Improvements
Record Gross Revenue: Achieved record annual gross revenue of $46.0 million, representing a 32% increase from $34.9 million in 2023. Fourth Quarter Results: Gross revenue reached an all-time quarterly high of $13.3 million in Q4 2024, marking a 20% …

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ongoing and first prescriptions filled Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; …

Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities into 2027 Strengthened cash position expected to support the Company through first substantive data readout in …

Progress Announces First Quarter 2025 Financial Results
Annualized Recurring Revenue ("ARR") of $836 million Grew 48% year-over-year Revenue of $238 million Grew 29% year-over-year ShareFile Integration Underway BURLINGTON, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Progress (Nasdaq: PRGS), the trusted provider …

Expion360 Reports Fourth Quarter and Full Year 2024 Financial Results
Q4 Sequential Revenue Growth of 43% Driven by New Products and Technologies, and 131% Year over Year New OEM and Distributor Relationships to Equip New Campers and RVs with Advanced Lithium-Ion Batteries Began Shipping e360 Home Energy Storage Solutions …

Pathfinder Bancorp, Inc. Declares Dividend
OSWEGO, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- James A. Dowd, President and CEO of Pathfinder Bancorp, Inc., the bank holding company of Pathfinder Bank (NASDAQ: PBHC) (listing: PathBcp), has announced that the Company has declared a cash dividend of $0. …

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
- Announced preclinical data demonstrating the bioequivalence of RT-114, a GLP-1/GLP-2 dual agonist (PG-102) delivered orally via the RaniPill® capsule, to subcutaneous administration of PG-102 - - Announced preclinical data demonstrating successful oral …

Birchtech Reports Fourth Quarter 2024 Financial Results
Company Drives Fourth Quarter 2024 Revenues of $5.6 Million; Leverages World-Class Activated Carbon Expertise to Launch New Water Purification Business CORSICANA, Texas, March 31, 2025 (GLOBE NEWSWIRE) -- Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) (" …

Aqua Metals Reports Milestone Advancements, Strategic Progress, and Sierra ARC Lithium Battery Recycling Campus Developments in 2024
RENO, Nev., March 31, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium battery recycling, today announced key achievements from 2024 and outlined progress for 2025 as the Company delivered critical technical …

MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
Addison, TX, March 31, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today provides an update on operations through and subsequent to …

Open Lending Reports Fourth Quarter and Full Year 2024 Financial Results
AUSTIN, Texas, March 31, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), an industry trailblazer in lending enablement and risk analytics solutions for financial institutions, today reported financial …

INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results
- Infrastructure: DBM Global fourth quarter revenue of $225.7 million - - Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) system received FDA approval to assess kidney function - - Spectrum: Broadcasting achieved double-digit revenue growth in the …

Open Lending Announces Leadership Changes
Board Chair Jessica Buss Appointed Chief Executive Officer Charles “Chuck” Jehl will Continue to Serve as Interim Chief Financial Officer and a Member of the Board of Directors Michelle Glasl Appointed Chief Operating Officer AUSTIN, Texas, March 31, 2025 …